Imipenem
Primaxin, Recarbrio (imipenem) is a small molecule pharmaceutical. Imipenem was first approved as Primaxin on 1985-11-26. It is used to treat bacterial endocarditis, bacterial infections, enterobacteriaceae infections, infectious bone diseases, and intraabdominal infections amongst others in the USA. It has been approved in Europe to treat gram-negative bacterial infections.
| Trade Name | Recarbrio |
|---|---|
| Common Name | Imipenem |
| Indication | bacterial endocarditis, bacterial infections, enterobacteriaceae infections, gram-negative bacterial infections, infectious bone diseases, intraabdominal infections, pelvic infection, pseudomonas infections, respiratory tract infections, staphylococcal infections, streptococcal infections, urinary tract infections |
| Drug Class | Antibacterial antibiotics, carbapenem derivatives |
